Home/Filings/4/0000950142-17-001789
4//SEC Filing

Malkani Sanjay 4

Accession 0000950142-17-001789

CIK 0001145460other

Filed

Oct 2, 8:00 PM ET

Accepted

Oct 3, 5:36 PM ET

Size

37.8 KB

Accession

0000950142-17-001789

Insider Transaction Report

Form 4
Period: 2017-10-03
Malkani Sanjay
Pres., Toxicology
Transactions
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2017-10-037,5000 total
    Exercise: $26.06Common Stock (7,500 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2017-10-033,9000 total
    Exercise: $25.43Common Stock (3,900 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2017-10-036,1330 total
    Exercise: $35.58Common Stock (6,133 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2017-10-0310,0000 total
    Exercise: $38.01Common Stock (10,000 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2017-10-035,0000 total
    Exercise: $38.64Common Stock (5,000 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2017-10-0325,0000 total
    Exercise: $19.20Common Stock (25,000 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2017-10-0345,0000 total
    Exercise: $45.47Common Stock (45,000 underlying)
  • Disposition to Issuer

    Common Stock

    2017-10-0328,7570 total
  • Disposition to Issuer

    Common Stock

    2017-10-035650 total(indirect: See footnote)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2017-10-0310,0000 total
    Exercise: $37.14Common Stock (10,000 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2017-10-0325,0000 total
    Exercise: $33.73Common Stock (25,000 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2017-10-0316,0400 total
    Exercise: $44.64Common Stock (16,040 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2017-10-0315,0000 total
    Exercise: $25.68Common Stock (15,000 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2017-10-032,5000 total
    Exercise: $18.91Common Stock (2,500 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2017-10-033,3750 total
    Exercise: $36.74Common Stock (3,375 underlying)
  • Disposition to Issuer

    Restricted Stock Units

    2017-10-0319,4700 total
    Common Stock (19,470 underlying)
Footnotes (4)
  • [F1]Pursuant to that certain Agreement and Plan of Merger, dated as of January 30, 2016, as amended on April 13, 2017 (the "Merger Agreement"), between Alere Inc. (the "Company") and Abbott Laboratories, at the Effective Time (as defined in the Merger Agreement) (the "Effective Time"), each of these shares of the Company's common stock (the "Common Stock") was converted into the right to receive $51.00 (the "Merger Consideration").
  • [F2]Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option.
  • [F3]Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Pursuant to the Merger Agreement, at the Effective Time, each outstanding Restricted Stock Unit was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock subject to such Restricted Stock Unit immediately prior to the Effective Time and (ii) the Merger Consideration.
  • [F4]These securities are owned by the reporting person's spouse. The reporting person hereby disclaims ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for the purpose of Section 16.

Issuer

ALERE INC.

CIK 0001145460

Entity typeother

Related Parties

1
  • filerCIK 0001571523

Filing Metadata

Form type
4
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 5:36 PM ET
Size
37.8 KB